D. Western Therapeutics Institute, Inc. (4576.T)
JPY 233.0
(14.22%)
JPY 233.0
(14.22%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 885.12 Million JPY | -8.53% |
| 2022 | 967.69 Million JPY | 184.62% |
| 2021 | 340 Million JPY | -26.09% |
| 2020 | 460 Million JPY | -4.17% |
| 2019 | 480 Million JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.1 Billion JPY | 11.56% |
| 2024 Q1 | 994.12 Million JPY | 12.31% |
| 2023 Q4 | 885.12 Million JPY | 7.14% |
| 2023 FY | 885.12 Million JPY | -8.53% |
| 2023 Q3 | 826.12 Million JPY | -0.29% |
| 2023 Q2 | 828.48 Million JPY | -3.76% |
| 2023 Q1 | 860.85 Million JPY | -10.98% |
| 2022 Q4 | 967 Million JPY | -13.14% |
| 2022 Q3 | 1.11 Billion JPY | 0.0% |
| 2022 FY | 967.69 Million JPY | 184.62% |
| 2021 FY | 340 Million JPY | -26.09% |
| 2020 FY | 460 Million JPY | -4.17% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 64.161% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 76.074% |
| Linical Co., Ltd. | 3 Billion JPY | 70.515% |
| Trans Genic Inc. | 2.25 Billion JPY | 60.784% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -38266.797% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 64.191% |
| AnGes, Inc. | 362.67 Million JPY | -144.054% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -728.386% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 98.803% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -275.08% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 20.181% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -383.75% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| RaQualia Pharma Inc. | 367.71 Million JPY | -140.707% |
| Chiome Bioscience Inc. | 291 Million JPY | -204.166% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 65.626% |
| PeptiDream Inc. | 22.79 Billion JPY | 96.118% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | -180.84% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | -33.101% |
| Healios K.K. | 4.53 Billion JPY | 80.47% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -686.775% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -519.603% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -807.427% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | 5.162% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | 8.562% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | -22.266% |
| StemCell Institute Inc. | 8.78 Million JPY | -9976.526% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -485.205% |